Position in CELC
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$81,533,510
-$15,924,235 QoQ
Shares Held
714,329
-26.9% QoQ
Ownership
1.46%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 97.16363188390783.ToString("F0")%
Shared 0.ToString("F0")%
None 2.836368116092165.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,405,235 across 346 Biotechnology names. CELC ranks #23 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in CELC
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $81,533,510 | 714,329 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $97,457,745 | 977,118 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $26,652,631 | 539,527 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $3,509,367 | 262,874 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,544,979 | 251,729 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,773,309 | 288,259 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,135,317 | 277,352 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,777,145 | 230,595 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,194,886 | 240,504 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $286,809 | 19,685 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $200,850 | 21,975 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $136,228 | 12,407 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $77,151 | 7,527 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $44,257 | 3,159 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $22,610 | 2,252 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $63 | 7 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $42,710 | 4,568 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $73,916 | 5,604 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $42,570 | 2,365 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $41,280 | 1,720 | Shares | Defined | 2021-09-13 | |
| 2020-09-30 | $220 | 38 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $144 | 21 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $9,600 | 1,477 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||